dc.contributor
Institut Català de la Salut
dc.contributor
[Rejeski K] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany. German Cancer Consortium (DKTK), Munich Site, and German Cancer Research Center, Heidelberg, Germany. [Burchert A] Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany. [Iacoboni G, Barba P] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma of Barcelona, Bellaterra, Spain. [Sesques P] Hospices Civils de Lyon, Universite Claude Bernard Lyon 1, INSERM 1052, Pierre-B enite, France. [Fransecky L] Medical Department II–Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. [Bücklein V] Department of Medicine III, Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Burchert, Andreas
dc.contributor.author
SESQUES, Pierre
dc.contributor.author
Fransecky, Lars
dc.contributor.author
Rejeski, Kai
dc.contributor.author
Barba, Pere
dc.contributor.author
Bücklein, Veit
dc.contributor.author
IACOBONI, GLORIA
dc.date.issued
2023-05-24T11:35:19Z
dc.date.issued
2023-05-24T11:35:19Z
dc.date.issued
2022-08-23
dc.identifier
Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Bücklein V, et al. Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood Adv. 2022 Aug 23;6(16):4719-25.
dc.identifier
https://hdl.handle.net/11351/9612
dc.identifier
10.1182/bloodadvances.2022007776
dc.identifier
000863968700001
dc.description.abstract
Stem cell; Hematotoxicity; T-cell
dc.description.abstract
Células madre; Hematotoxicidad; Células T
dc.description.abstract
Cèl·lules mare; Hematotoxicitat; Cèl·lules T
dc.description.abstract
This work was supported by a fellowship from School of Oncology of German Cancer Consortium (DKTK) (K.R.) and was funded by the Else Kröner Forschungskolleg; a Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) research grant provided within the Sonderforschungbereich (SFB-TRR 388/1 2021–452881907) and DFG research grant (451580403) (M.S.); the Bavarian Elite Graduate Training Network (M.S.), the Wilhelm-Sander Stiftung (project no. 2018.087.1) (M.S.), the Else-Kröner-Fresenius Stiftung (M.S., K.R., V. Bücklein, V. Blumenberg), and the Bavarian Center for Cancer Research (BZKF).
dc.format
application/pdf
dc.publisher
American Society of Hematology
dc.relation
Blood Advances;6(16)
dc.relation
https://doi.org/10.1182/bloodadvances.2022007776
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Cèl·lules mare
dc.subject
Estudis de viabilitat
dc.subject
Teràpia cel·lular
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics::Feasibility Studies
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Salvage Therapy
dc.subject
ANATOMY::Cells::Stem Cells
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Immunologic Techniques::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::características de los estudios epidemiológicos::estudios de viabilidad
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamiento de última línea
dc.subject
ANATOMÍA::células::células madre
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas inmunológicas::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva
dc.title
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
